4//SEC Filing
Reardon Andrew 4
Accession 0002001011-25-000016
CIK 0000886163other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:55 PM ET
Size
7.2 KB
Accession
0002001011-25-000016
Insider Transaction Report
Form 4
Reardon Andrew
CLO & Secretary
Transactions
- Award
Common Stock
2025-03-04+6,415→ 34,783 total - Award
Employee Stock Option (right to buy)
2025-03-04+28,043→ 28,043 totalExercise: $115.26Exp: 2035-03-04→ Common Stock (28,043 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on February 15, 2026; February 15, 2027; and February 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001950232
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:55 PM ET
- Size
- 7.2 KB